AC
Armistice Capital Portfolio holdings
AUM
$4.08B
1-Year Est. Return
30.47%
This Fund
S&P 500
1 Year Est. Return
+30.47%
AUM
$3.19B
AUM Growth
+$548M
(+21%)
Holding
386
Top Buys
| 1 | +$76M | |
| 2 | +$43.1M | |
| 3 | +$41.5M | |
| 4 |
Starbucks
SBUX
|
+$31.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$30.3M |
Top Sells
| 1 | +$79.6M | |
| 2 | +$76M | |
| 3 | +$50.6M | |
| 4 |
STAAR Surgical
STAA
|
+$47.2M |
| 5 |
Travere Therapeutics
TVTX
|
+$40.5M |
Sector Composition
| 1 | Healthcare | 67.5% |
| 2 | Technology | 11.71% |
| 3 | Consumer Discretionary | 11.16% |
| 4 | Communication Services | 4.26% |
| 5 | Consumer Staples | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Dollar Tree
DLTR
$23.5B
| – | – |
-4,248
|
|
||
377
Darden Restaurants
DRI
$24.2B
| – | – |
-36,443
|
|
||
378
Brinker International
EAT
$6.14B
| – | – |
-125,827
|
|
||
379
Enlivex Ltd. Ordinary Shares
ENLV
$285M
| – | – |
-1,413,306
|
|
||
|
NXLIW
380
DELISTED
Nexalin Technology Inc Warrant
NXLIW
| – | – |
-325,000
|
|
||
381
NextCure
NXTC
$42.2M
| – | – |
-8,667
|
|
||
|
OTRK
382
DELISTED
Ontrak
OTRK
| – | – |
-356,666
|
|
||
383
PDS Biotechnology
PDSB
$36.5M
| – | – |
-2,236,000
|
|
||
384
Senti Biosciences
SNTI
$25M
| – | – |
-892,207
|
|
||
|
MKZR
385
MacKenzie Realty Capital
MKZR
$6.92M
| – | – |
-124,374
|
|
||
|
KMTS
386
Kestra Medical Technologies
KMTS
$1.34B
| – | – |
-22,834
|
|